Types of Vaccine Ingredients
To help understand vaccine ingredients it’s useful to divide them into 3 parts.
- The vaccine substrate (how it’s grown)
- The antigen itself (what is designed to create an antibody response)
- Excipients, stabilizers, adjuvants, etc. (other ingredients the vaccine contains to make it stable or last or stimulate a better immune response)
Vaccine Substrate
Vaccines are and have been grown on all types of animal and human cells. Parts of these cells (proteins, DNA, detritus) often make their way into the final product. Here are a few examples:
Monkey Cells Led to Monkey Viruses
Cancer causing monkey virus (SV40) in millions of doses of polio vaccine. See for example:
- Simian Virus 40 Infection of Humans. Robert L. Garcea1 and Michael J. Imperiale, J Virol. 2003 May; 77(9): 5039–5045.
Pig Cells Led to Pig Viruses
Pig viruses (PCV 1 and 2 fragments) in rotavirus vaccines. See for example:
- Detection of PCV-2 DNA in stool samples from infants vaccinated with RotaTeq® Mathew D Esona,et al., Hum Vaccin Immunother. 2014 Jan 1; 10(1): 25–32.
Chicken Egg Cells Led to Bird Viruses
Bird viruses (endogenous avian leukosis viruses and endogenous avian viruses) in measles vaccines. See for example:
- Evidence of Avian Leukosis Virus Subgroup E and Endogenous Avian Virus in Measles and Mumps Vaccines Derived from Chicken Cells: Investigation of Transmission to Vaccine Recipients. Shirley X. Tsang, et al., J Virol. 1999 Jul; 73(7): 5843–5851.
Vaccine Culture Media and Excipients
Here’s a list of vaccine culture media and excipients. An excipient is defined as
“an inactive substance that serves as the vehicle or medium for a drug or other active substance. Excipients are things like coloring agents, preservatives, and fillers.”
- From Wikipedia
Vaccine | Culture media | Excipients |
---|---|---|
Adenovirus vaccine | Dulbecco's Modified Eagle Medium, human diploid fibroblast cell culture (WI-38) | This list refers to the type 4 and type 7 adenovirus vaccine tablets licensed in the US: Acetone, alcohol, anhydrous lactose, castor oil, cellulose acetate phthalate, dextrose, D-fructose, D-mannose, FD&C Yellow #6 aluminum lake dye, fetal bovine serum, human serum albumin, magnesium stearate, micro crystalline cellulose, plasdone C, Polacrilin potassium, potassium phosphate, sodium bicarbonate, sucrose |
Anthrax vaccine (BioThrax) | Puziss–Wright medium 1095, synthetic or semisynthetic | Aluminum hydroxide, amino acids, benzethonium chloride, formaldehyde, inorganic salts and sugars, vitamins |
BCG (Bacillus Calmette-Guérin) (Tice BCG) | Synthetic or semisynthetic | Asparagine, citric acid, lactose, glycerin, iron ammonium citrate, magnesium sulfate, potassium phosphate |
DTaP (Daptacel) | Cohen–Wheeler or Stainer–Scholte media, synthetic or semisynthetic | Aluminum phosphate, formaldehyde, Glutaraldehyde, 2-phenoxyethanol |
DTaP (Infanrix) | Cohen–Wheeler or Stainer–Scholte media, Lathan medium derived from bovine casein, Linggoud–Fenton medium derived from bovine extract, synthetic or semisynthetic | Aluminum hydroxide, bovine extract, formaldehyde, glutaraldhyde, polysorbate 80 |
DTaP (Tripedia) | Cohen–Wheeler or Stainer–Scholte media, synthetic or semisynthetic | Aluminum potassium sulfate, ammonium sulfate, bovine extract, formaldehyde, gelatin, peptone, polysorbate 80, sodium phosphate, thimerosal[2] |
DTaP-Hib (TriHIBit) | Synthetic or semisynthetic | Aluminum potassium sulfate, ammonium sulfate, bovine extract, formaldehyde or formalin, gelatin, polysorbate 80, sucrose, thimerosal[2] |
DTaP-IPV (Kinrix) | Vero (monkey kidney) cell culture, synthetic or semisynthetic | Aluminum hydroxide, calf serum, formaldehyde, glutaraldehyde, lactalbumin hydrolysate, neomycin sulfate, polymyxin B, polysorbate 80 |
DTaP-HepB-IPV (Pediarix) | Bovine protein, Lathan medium derived from bovine casein, Linggoud–Fenton medium derived from bovine extract, Vero (monkey kidney) cell culture, synthetic or semisynthetic | Aluminum hydroxide, aluminum phosphate, calf serum, lactalbumin hydrolysate, formaldehyde, glutaraldhyde, neomycin sulfate, polymyxin B, polysorbate 80, yeast protein |
DTaP-IPV-Hib (Pentacel) | Synthetic or semisynthetic | Aluminum phosphate, bovine serum albumin, formaldehyde, glutaraldehyde, MRC-5 cellular protein, neomycin, polymyxin B sulfate, polysorbate 80, 2-phenoxyethanol |
DT vaccine (diphtheria vaccine plus tetanus vaccine) (Sanofi) | Synthetic or semisynthetic | Aluminum potassium sulfate, bovine extract, formaldehyde, thimerosal |
DT vaccine (Massachusetts) | Synthetic or semisynthetic | Aluminum hydroxide, formaldehyde or formalin |
Hib vaccine (ActHIB) | Synthetic or semisynthetic | Ammonium sulfate, formaldehyde, sucrose[3] |
Hib vaccine (PedvaxHib) | Synthetic or semisynthetic | Aluminum hydroxyphosphate sulfate[4] |
Hib vaccine (Hiberix) | Semisynthetic | Formaldehyde, lactose[5] |
Hib-HepB (Comvax) | Synthetic or semisynthetic, yeast or yeast extract | Amorphous aluminum hydroxyphosphate sulfate, amino acids, dextrose, formaldehyde, hemin chloride, mineral salts, nicotinamide adenine dinucleotide, potassium aluminum sulfate, sodium borate, soy peptone, yeast protein |
Hepatitis A vaccine (Havrix) | Human diploid tissue culture (MRC-5) | Aluminum hydroxide, amino acid supplement, formalin, MRC-5 cellular protein, neomycin sulfate, phosphate buffers, polysorbate 20 |
Hepatitis A vaccine (Vaqta) | Human diploid tissue culture (MRC-5) | Amorphous aluminum hydroxyphosphate sulfate, bovine albumin or serum, formaldehyde, MRC-5 cellular protein, sodium borate |
Hepatitis B vaccine (Engerix-B) | Yeast or yeast extract | Aluminum hydroxide, phosphate buffers, yeast protein |
Hepatitis B vaccine (Recombivax HB) | Yeast or yeast extract | Amorphous aluminum hydroxyphosphate sulfate, amino acids, dextrose, formaldehyde, mineral salts, potassium aluminum sulfate, soy peptone, yeast protein |
HepA-HepB vaccine (Twinrix) | Human diploid tissue culture (MRC-5), yeast or yeast extract | Aluminum hydroxide, aluminum phosphate, amino acids, formalin, MRC-5 cells, neomycin sulfate, phosphate buffers, polysorbate 20, yeast protein |
Human papillomavirus (HPV) (Cervarix) | Trichoplusia ni cells | Aluminum hydroxide, amino acids, lipids, mineral salts, sodium dihydrogen phosphate dehydrate, type 16 viral protein L1, type 18 viral protein L1, vitamins |
Human papillomavirus (HPV) (Gardasil) | Yeast or yeast extract | Amino acids, amorphous aluminum hydroxyphosphate sulfate, carbohydrates, L-histidine, mineral salts, polysorbate 80, sodium borate, vitamins, yeast protein |
Influenza vaccine (Afluria) | Chicken embryo | Beta-propiolactone, calcium chloride, dibasic sodium phosphate, egg protein, monobasic potassium phosphate, monobasic sodium phosphate, neomycin sulfate, polymyxin B, potassium chloride, sodium taurodeoxychoalate, thimerosal (multi-dose vials only) |
Influenza vaccine (Agriflu) | Chicken embryo | Egg proteins, formaldehyde, polysorbate 80, cetyltrimethylammonium bromide, neomycin sulfate, kanamycin |
Influenza vaccine (Fluad) | Chicken embryo | Squalene, polysorbate 80, sorbitan trioleate, sodium citrate dehydrate, citric acid monohydrate, neomycin, kanamycin, barium, egg proteins, CTAB(cetyltrimethylammonium bromide), formaldehyde |
Influenza vaccine (Fluarix) | Chicken embryo | Formaldehyde, octoxynol-10 (Triton X-100), α-tocopheryl hydrogen succinate, polysorbate 80 (Tween 80), hydrocortisone, gentamicin sulfate, ovalbumin, sodium deoxycholate, sucrose, phosphate buffer |
Influenza vaccine (Flublok) | insect cell line (expresSF+) | Monobasic sodium phosphate, dibasic sodium phosphate, polysorbate 20, baculovirus and host cell proteins, baculovirus and cellular DNA, Triton X-100, lipids, vitamins, amino acids, mineral salts |
Influenza vaccine (Flucelvax) | Madin Darby Canine Kidney (MDCK) cell protein | Madin Darby Canine Kidney (MDCK) cell protein, MDCK cell DNA, polysorbate 80, cetyltrimethlyammonium bromide, β-propiolactone, phosphate buffer |
Influenza vaccine (Flulaval) | Chicken embryo | Formaldehyde, á-tocopheryl hydrogen succinate, polysorbate 80, sodium deoxycholate, thimerosal, ovalbumin |
Influenza vaccine (Fluvirin) | Chicken embryo | Beta-propiolactone, egg protein, neomycin, nonylphenol ethoxylate, polymyxin, thimerosal (multi-dose containers), thimerosal[2] (single-dose syringes) |
Influenza vaccine (Fluzone) | Chicken embryo | Egg protein, formaldehyde, gelatin (standard formulation only), octylphenol ethoxylate (Triton X-100), sodium phosphate, thimerosal (multi-dose containers only) |
Influenza vaccine (FluMist) | Chicken kidney cells, chicken embryo | Arginine, dibasic potassium phosphate, egg protein, ethylenediaminetetraacetic acid, gentamicin sulfate, hydrolyzed porcine gelatin, monobasic potassium phosphate, monosodium glutamate, sucrose |
Japanese encephalitis vaccine (JE-Vax) | Mouse brain culture | Formaldehyde or formalin, gelatin, mouse serum protein, polysorbate 80, thimerosal |
Japanese encephalitis vaccine (Ixiaro) | Vero (monkey kidney) cell culture | Aluminum hydroxide, bovine serum albumin, formaldehyde, protamine sulfate, sodium metabisulphite |
Meningococcal vaccine (Menactra) | Modified Mueller–Miller medium, Mueller–Hinton agar, Watson–Scherp medium | Formaldehyde (Each 0.5 mL dose may contain residual amounts of formaldehyde of less than 2.66 µg (0.000532%), by calculation), phosphate buffers[6] |
Meningococcal vaccine (Menomune) | Watson–Scherp media, Mueller–Hinton agar | Lactose, thimerosal (multi-dose vial only) |
Meningococcal vaccine (Menveo) | Franz complete medium | Amino acids, formaldehyde, yeast extract |
MMR vaccine (MMR-II) | Human diploid tissue culture (WI-38), Medium 199 | Amino acids, fetal bovine serum, glutamate, hydrolyzed gelatin, neomycin, recombinant human serum albumin, sodium phosphate, sorbitol, sucrose, vitamins |
MMRV vaccine (ProQuad) | Human diploid tissue cultures (MRC-5, WI-38), Medium 199 | Bovine calf serum, dibasic potassium phosphate, dibasic sodium phosphate, human albumin, human serum albumin, hydrolyzed gelatin, monobasic potassium phosphate, monosodium L-glutamate, MRC-5 cellular protein, neomycin, sodium bicarbonate, sorbitol, sucrose, potassium chloride |
Pneumococcal vaccine (Pneumovax) | Bovine protein | Phenol |
Pneumococcal vaccine (Prevnar) | Soy peptone broth | Aluminum phosphate, ammonium sulfate, casamino acid, polysorbate 80, succinate buffer, yeast |
Polio vaccine (IPV – Ipol) | Vero (monkey kidney) cell culture, Medium 199 | Calf serum protein, formaldehyde, neomycin, 2-phenoxyethanol, polymyxin B, streptomycin |
Polio vaccine (IPV – Poliovax) | Human diploid tissue culture (MRC-5) | sodium chloride |
Rabies vaccine (Imovax) | Human diploid tissue culture (MRC-5) | Albumin, MRC-5 cells, neomycin sulfate, phenol |
Rabies vaccine (RabAvert, Greedo) | Rhesus fetal lung tissue culture, chicken embryo | Amphotericin B, beta-propiolactone, chicken protein, chlortetracycline, human serum albumin, neomycin, ovalbumin, polygeline (processed bovine 14 gelatin), potassium glutamate |
Rotavirus vaccine (RotaTeq) | Vero (monkey kidney) cell culture | fetal bovine serum, sodium citrate, sodium phosphate monobasic monohydrate, sodium hydroxide, sucrose, polysorbate 80 |
Rotavirus vaccine (Rotarix) | Dulbecco's Modified Eagle Medium (DMEM) | Amino acids, calcium carbonate, dextran, sorbitol, sucrose, vitamins, xanthan |
Td vaccine (Decavac) | Mueller–Miller medium, synthetic or semisynthetic | Aluminum potassium sulfate, bovine muscle tissue, formaldehyde, peptone, thimerosal[2] |
Td vaccine (Massachusetts) | Modified Mueller's media, synthetic or semisynthetic | Aluminum phosphate, ammonium phosphate, bovine extracts, formaldehyde, thimerosal (some multi-dose vials) |
Tdap vaccine (Adacel) | Mueller's growth medium, Mueller–Miller casamino acidmedium(without beef heart infusion), synthetic or semisynthetic | Aluminum phosphate, ammonium sulfate, formaldehyde, glutaraldehyde, 2-phenoxyethanol |
Tdap vaccine (Boostrix) | Fenton media with bovine casein, Lathan medium derived from bovine casein, Linggoud–Fenton medium derived from bovine extract, Stainer–Scholte liquid medium, synthetic or semisynthetic | Aluminum hydroxide, bovine extract, formaldehyde, glutaraldehyde, polysorbate 80 |
Typhoid vaccine (inactivated – Typhim VI) | Synthetic or semisynthetic | Disodium phosphate, monosodium phosphate, phenol, polydimethylsiloxane, hexadecyltrimethylammonium bromide |
Typhoid vaccine (oral – Ty21a/Vivotif) | Amino acids, ascorbic acid, casein, dextrose, galactose, lactose, sucrose, yeast extract | |
Vaccinia (ACAM2000) | Vero (monkey kidney) cell culture | Glycerin, human serum albumin, mannitol, neomycin, phenol, polymyxin B |
Varicella vaccine (Varivax) | Human diploid tissue cultures (MRC-5 and WI-38) | Dibasic sodium phosphate, ethylenediamine tetra acetic acid[ sodium (EDTA), fetal bovine serum, gelatin, glutamate, monobasic potassium phosphate, monobasic sodium phosphate, monosodium L-glutamate, MRC-5 DNA and cellular protein, neomycin, phosphate, potassium chloride, sucrose |
Yellow fever vaccine (YF-Vax) | Chicken embryo | Egg protein, gelatin, sorbitol |
Zoster vaccine (Zostavax) | Human diploid tissue cultures (MRC-5 and WI-38) | Bovine calf serum, dibasic sodium phosphate, hydrolyzed porcine gelatin, monosodium L-glutamate, MRC-5 DNA and cellular protein, monobasic potassium phosphate, neomycin, potassium chloride, sucrose |
Even Small Doses of an Unhealthy Ingredient Can be Dangerous to Some Children
Studies demonstrate that even low levels of toxic substances like mercury or aluminum (which is in some vaccines) can be dangerous.
“A core assumption of traditional toxicology is “the dose makes the poison.” Generations of toxicologists have begun their studies by learning this, countless experiments have provided support, and the laws protecting people from undue exposure all assume that it is true.
“The dose makes the poison” is taken to mean that the higher the dose, the greater the effect. And this implies that low exposures are less important. Indeed, based on “the dose makes the poison” it is commonly argued that “background” levels of contamination aren’t worth worrying about.
Yet new evidence emerging from modern scientific research that combines toxicology, developmental biology, endocrinology and biochemistry is demonstrating that this assumption is wrong, at least in its simplest and most-widely used form. And the implications for this new realization are profound, because it means that the safety standards used to protect public health are built upon false assumptions and likely to be inadequate.”
Small Doses Can be Dangerous
This paper focuses on endocrine disrupting chemicals and concludes that small doses may be as dangerous or, in some cases, more dangerous than large doses.
Dangerous Effects from Low Levels of Mercury
Mercury (hg) is in some vaccines. Low doses can cause injury. Here are just a few scientific articles that make this point that mercury is dangerous to the brain. What does it do to children’s brains that are still developing?
“Numerous studies have reported neurobehavioural effects in dental personnel occupationally exposed to chronic low levels of mercury (Hg).” (emphasis added)
- Neurotoxic effects of mercury exposure in dental personnel.; Geir Bjørklund, et al., Basic Clin Pharmacol Toxicol. 2019 May;124(5):568-574.
“These results suggest …that humans chronically exposed to low doses of Hg may be at risk of autoimmunity induction regardless of their genetic background.” (emphasis added)
- Low doses of mercuric chloride cause the main features of anti-nucleolar autoimmunity in female outbred CFW mice. Alla S Arefieva, et al., Toxicol Ind Health. 2016 Sep;32(9):1663-74.
“Our study provides novel evidence…that developmental exposure to low levels of MeHg may result in long-term consequences predisposing to neurodevelopmental disorders and/or neurodegeneration.” (emphasis added)
- Inherited effects of low-dose exposure to methylmercury in neural stem cells. Raj Bose, et al., Toxicol Sci. 2012 Dec;130(2):383-90.
“Thimerosal (an ethylmercury-containing compound used as a preservative in vaccines )…22 studies from 1971 to 2019 show that exposure to ethylmercury-containing compounds (intravenously, intraperitoneally, topically, subcutaneously, intramuscularly, or intranasally administered) results in accumulation of mercury in the brain. In total, these studies indicate that ethylmercury-containing compounds and Thimerosal readily cross the Blood-brain-barrier, convert, for the most part, to highly toxic inorganic mercury-containing compounds, which significantly and persistently bind to tissues in the brain, even in the absence of concurrent detectable blood mercury levels.”
- Examining the evidence that ethylmercury crosses the blood-brain barrier. Janet K Kern, et al., Environ Toxicol Pharmacol. 2020 Feb;74:103312. doi: 10.1016/j.etap.2019.103312. Epub 2019 Dec 9.
Dangerous Effects from Low Levels of Aluminum
Aluminum is in some vaccines. Here are scientific articles that discuss how even low doses of aluminum are dangerous, especially to the nervous system.
“The effects of low-dose Al were similar to those found in rats exposed to Al at a dose much higher (100mg/kg). Our findings suggest that Al may be considered toxic for the peripheral nervous system, thus inducing peripheral dysfunction.” (emphasis added)
- Aluminum exposure for 60days at an equivalent human dietary level promotes peripheral dysfunction in rats. Caroline Silveira Martinez, et al., J Inorg Biochem. 2018 Apr;181:169-176.
“Aluminium (Al) oxyhydroxide (Alhydrogel®), the main adjuvant licensed for human and animal vaccines, consists of primary nanoparticles that spontaneously agglomerate. Concerns about its safety emerged following recognition of its unexpectedly long-lasting biopersistence within immune cells in some individuals, and reports of chronic fatigue syndrome, cognitive dysfunction, myalgia, dysautonomia and autoimmune/inflammatory features temporally linked to multiple Al-containing vaccine administrations.
We conclude that Alhydrogel® injected at low dose in mouse muscle may selectively induce long-term Al cerebral accumulation and neurotoxic effects…the view that Alhydrogel® neurotoxicity obeys “the dose makes the poison” rule of classical chemical toxicity appears overly simplistic.” (emphasis added)
- Non-linear dose-response of aluminium hydroxide adjuvant particles: Selective low dose neurotoxicity. Guillemette Crépeaux, et al., Toxicology. 2017 Jan 15;375:48-57.
Disease is a product of genetics and environment
The fact that diseases result from the interaction of genetics and the environment is a well accepted principle of science.
“Few diseases result from a change in a single gene or even multiple genes. Instead, most diseases are complex and stem from an interaction between your genes and your environment.”
- Frome the National Institute of Environmental Health Sciences, a Division of the National Institute of Health
“Most diseases involve many genes in complex interactions, in addition to environmental influences.”
“[M]ultiple gene products and environmental factors interact to influence disease etiology in complex ways.”
Adverse reactions to vaccines can produce various diseases, based on genetics.
The video said:
- Some will get seizures and convulsions.
- Some will develop neurological disabilities.
- Some will get autoimmune diseases.
Here a just a few examples from the medical literature.
Seizures and Convulsions from Vaccines
“In the empirical data, we narrowed the association with seizure from all vaccines in the schedule to three likely candidates, DTaP, PCV, and/or Haemophilus influenzae type B (HiB).”
- Determining Which of Several Simultaneously Administered Vaccines Increase Risk of an Adverse Event. Shirley V Wang, et al., Drug Saf. 2020 Oct;43(10):1057-1065.
“Febrile seizures are associated with the first dose of measles-containing vaccines and the risk increases with chronologic age during the second year of life.”
- Similar relative risks of seizures following measles containing vaccination in children born preterm compared to full-term without previous seizures or seizure-related disorders. David L McClure, et al., Vaccine. 2019 Jan 3;37(1):76-79.
“Vaccination was found to be the second most common cause of febrile seizures.”
- The Influence of Vaccine on Febrile Seizure.Xin Li. Et al., Curr Neuropharmacol. 2018;16(1):59-65.
“These data suggest that the risk of febrile convulsion is increased in days 5-12 following vaccination with MMRV as compared to MMR+V given separately during the same visit, when post-vaccination fever and rash are also increased in clinical trials.”
- Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting. Steven J Jacobsen, et al., Vaccine. 2009 Jul 23;27(34):4656-61.
An elevated relative incidence of convulsion was found in the 6- to 11-day period after receipt of Priorix (MMR vaccine GlaxoSmithKline, London, United Kingdom).
- Risks of convulsion and aseptic meningitis following measles-mumps-rubella vaccination in the United Kingdom. E Miller, et al., Am J Epidemiol. 2007 Mar 15;165(6):704-9.
Neurological Disabilities from Vaccines
“Diphtheria, tetanus, and pertussis vaccine may on rare occasions be associated with the development of severe acute neurological illnesses that can have serious sequelae.”
- Pertussis immunisation and serious acute neurological illnesses in children. D Miller, et al., BMJ. 1993 Nov 6;307(6913):1171-6. doi: 10.1136/bmj.307.6913.1171.
Here are some examples from proceedings in the Federal Court of Claims:
“The Court found, as a matter of fact, that Benjamin would not have experienced the seizure disorder and acute encephalopathy or the marked deterioration in neurologic development evidenced by the medical record in this case, but for the administration of the MMR vaccine on 17 November 2004 and the ensuing seizure on 27 November 2004. As such, the law applicable in the Vaccine Program leads the Court to conclude that the vaccination at issue was the cause-in-fact of the injury discussed in the Court’s findings.”
In the United States Court of Federal Claims, No. 06-0120V, Filed: 30 July 2008, Case of Benjamin Zeller
About 600 more cases here:
Examples of Neurological Injuries from Vaccines: Source is VAERS
Currently, the only way for the public to access data about specific vaccine injuries is through VAERS. Established in 1990, the Vaccine Adverse Event Reporting System (VAERS) is a national early warning system to detect possible safety problems in U.S.-licensed vaccines. VAERS is co-managed by the Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA). Just because a report is in VAERS does not mean it is verified. The government has decided that reported vaccine injuries are not important enough to require a formal and independent follow-up inquiry. For more information see Part 9.
Event Information
Patient Age | 1.50 | Sex | Female |
State / Territory | Delaware | Date Report Completed | 2020-04-20 |
Date Vaccinated | 2020-03-24 | Date Report Received | 2020-04-20 |
Date of Onset | 2020-03-24 | Date Died | |
Days to onset | 0 | Granee | Non-Grantee |
Vaccine Administered By | Private | Vaccine Purchased By | No Applicable |
Mfr/Imm Project Number | NONE | Report Form Version | 2 |
Recovered | No | Serious | Yes |
VAERS ID: 868508-1
“Developed fever to 102.4 approximately 6 hours after vaccination. The next morning, was noted to be lethargic with seizure-like jerking of extremities. Admitted to our hospital, initial EEG was not consistent with seizures, but continued to have altered mental status. On 3/28/20, developed EEG-confirmed status epilepticus requiring intubation and 3 anti-epileptic medications to break seizures. Ultimately extubated on 3/30 and has continued to show steady improvement each day thereafter with no further seizures witnessed. Is now receiving inpatient rehabilitation.”
Event Information
Patient Age | 16.00 | Sex | Female |
State / Territory | Florida | Date Report Completed | 2020-02-01 |
Date Vaccinated | 2019-12-13 | Date Report Received | 2020-02-01 |
Date of Onset | 2019-12-15 | Date Died | |
Days to onset | 2 | Granee | Non-Grantee |
Vaccine Administered By | Private | Vaccine Purchased By | No Applicable * |
Mfr/Imm Project Number | NONE | Report Form Version | 2 |
Recovered | No | Serious | Yes |
VAERS ID: 858919-1
“My daughter has had the following wrong with her since December 13, 2019 we had went to the doctor let her know What was going on because she hasn?t been able to go to school due to all these issues from being sick and the doctor told us to report these events to Bear?s due to it being a reaction from the meningitis vaccine that she was given in December she hasn?t recovered and has been sick since the beginning of December from two days after being vaccinated… Every time she has a vaccine she has an injury and it is a struggle to just try to fill out something simple to get it reported there?s no simple form this whole process is ridiculous and long and strategic there?s no way to report every single vaccine injury even my own children it is a struggle just to get theirs reported an injury is so under reported. My daughter has many issues from birth just from being vaccine injured and her behavior and well-being has digressed from being vaccinated.”
Event Information
Patient Age | 14.00 | Sex | Female |
State / Territory | Tennessee | Date Report Completed | 2018-10-15 |
Date Vaccinated | 2018-09-21 | Date Report Received | 2018-10-15 |
Date of Onset | 2018-09-22 | Date Died | |
Days to onset | 1 | Granee | Non-Grantee |
Vaccine Administered By | Private | Vaccine Purchased By | No Applicable * |
Mfr/Imm Project Number | NONE | Report Form Version | 2 |
Recovered | No | Serious | Yes |
VAERS ID: 778109-1
“9/22/18 6:30 AM She woke up with a headache, swollen tongue and trouble talking and thinking. After that she had a mild headache daily until it got worse on 9/27/18. I took my daughter to the ER at 6:30 PM for meds to relieve the headache, they did not work and I had her at a different ER on 9/29/18 at 2:30 AM for the pain. This ER sent her to a pediatric hospital to be admitted. She stayed the night in Hospital and received meds via IV to get relief from the pain. She was back in the ER on 10/10/18 due to yet another migraine that this time involved hand tingling and mouth tingling. She once again received an IV and fluids and medication. She was released the same day and we followed up with a neurologist on 10/11/18 where she has been put on a daily medication to try to limit the amount of headaches that she gets. She now has headaches daily and lives in fear of a bad one that will possibly land her back in the hospital. Prior to getting the GARDASIL vaccine my daughter was healthy and did not have migraines. Before this vaccine she rarely even got a headache at all, much less one that we couldn’t get rid of!!!”
Event Information
Patient Age | 16.00 | Sex | Male |
State / Territory | Hawaii | Date Report Completed | 2020-01-10 |
Date Vaccinated | 2019-09-13 | Date Report Received | 2020-01-10 |
Date of Onset | 2019-09-13 | Date Died | |
Days to onset | 0 | Granee | Non-Grantee |
Vaccine Administered By | Private | Vaccine Purchased By | No Applicable * |
Mfr/Imm Project Number | NONE | Report Form Version | 2 |
Recovered | No | Serious | Yes |
VAERS ID: 856171-1
“Summary: Immediately following vaccines. extreme pain in right shoulder that go progressively worse. Went to bed as soon as he got home. Woke up with headache, skin sensitivity, lethargy. 9/18/2019: Patient still feeling lethargy, skin sensitivity, bad consistent headache. Called Dr. Dr said he probably has a virus. 9?19?2019: Took patient to ER for excruciating headache, photosensitivity, and skin sensitivity. They gave him medicine. Told us to follow up with dr. 9/20/2019: Saw Dr. She gave him Acetaminophen. She said headaches should dissipate. 9/23/2019: Took him back to see Dr. Noticed irregular eye movements. Still experiencing photosensitivity, constant extreme headache, and now irregular eye movement and dizziness. 9/23/2019: Admitted to Medical Center. After numerous testing, all came back negative. Took patient home on the 9/29/2019. To this day, patient continues to experience irregular eye movements , as well as dizziness, Must use a cane/walker, and can’t attend school.”
Event Information
Patient Age | 1.92 | Sex | Female |
State / Territory | Illinois | Date Report Completed | 2019-10-31 |
Date Vaccinated | 2019-10-24 | Date Report Received | 2019-10-31 |
Date of Onset | 2019-10-24 | Date Died | |
Days to onset | 0 | Granee | Non-Grantee |
Vaccine Administered By | Private | Vaccine Purchased By | No Applicable * |
Mfr/Imm Project Number | NONE | Report Form Version | 2 |
Recovered | Unknown | Serious | Yes |
VAERS ID: 844752-1
“Patient was at a clinic appointment and very well Thurs, Oct 24,2019. Her LFTs were normal for her baseline at lab draw. A few hours after her flu shot, she started vomiting. It went on for 2 days until she became lethargic and appeared jaundiced. On Saturday, Oct 26, 2019 I took her to ED where she presented with cholangitis and elevated lfts. She now has a biliary drain inserted. It should be noted that last year, she had a similar, although less severe response and was hospitalized with severe vomiting and elevated LFTs after her flu shot.”